title: [Chemotherapy selection through the process of gastric cancer].
abstract: The role of chemotherapy has become more and more important in the whole process of gastric cancer. S-1 or XELOX regimen is regarded as the standard treatment option in adjuvant chemotherapy. First-line chemotherapy in advanced gastric cancer has been established to improve survival, and the benefit from second-line chemotherapy is being acknowledged. More studies are needed to assess the neoadjuvant chemotherapy.
authors.affiliation: Department of Medical Oncology, Fudan University, Shanghai, China. liu.tianshu@zs-hospital.sh.cn
authors.forename: Tian-Shu
authors.initials: TS
authors.lastname: Liu
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D006801:Humans; D013274:Stomach Neoplasms / Q000188:drug therapy*